Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
perfusion computed tomography
DEVICE
2 trials
Sponsors
Stanford University
, Assistance Publique - Hôpitaux de Paris
Conditions
Hepatocellular Carcinoma
Metastatic Renal Cell Cancer
Unknown Phase
Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma
Completed
NCT01926990
Stanford University
Metastatic Renal Cell Cancer
Start: 2014-08-31
End: 2021-12-17
Updated: 2022-02-02
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma
NCT03754192
Assistance Publique - Hôpitaux de Paris
Hepatocellular Carcinoma
Start: 2019-01-30
End: 2020-12-30
Target: 50
Updated: 2020-09-01
Related Papers
Evaluation of perfusion CT and dual-energy CT for predicting microvascular invasion of hepatocellular carcinoma.
2022-04-13
27 citations
Do CT perfusion measures predict early clinical response in patients with advanced renal cell carcinoma?
Journal of Clinical Oncology
2017-02-20